Fistula Global Clinical Trials Review, H2, 2015

1
Fistula Global Clinical Trials Review, H2, 2015
(Type, Mode of action, Crop Type and Geography) -
Size, Share, Global Trends, Company Profiles,
Demand, Insights, Analysis, Research, Report,
Opportunities, Segmentation and Forecast, 2013 -
2020
TELEPHONE [phone]E-MAIL
sales_at_researchbeam.com
Published on Oct 2014
2


Report Overview

• Fistula Global Clinical Trials Review, H2, 2015
  provides an overview of Fistula clinical trials
  scenario. This report provides top line data
  relating to the clinical trials on Fistula.
  Report includes an overview of trial numbers and
  their average enrollment in top countries
  conducted across the globe. The report offers
  coverage of disease clinical trials by region,
  country (G7 E7), phase, trial status, end
  points status and sponsor type. Report also
  provides prominent drugs for in-progress trials
  (based on number of ongoing trials).
• Scope
• - The report provides a snapshot of the global
  clinical trials landscape
• - Report provides top level data related to the
  clinical trials by Region, Country (G7 E7),
  Trial Status, Trial Phase, Sponsor Type and End
  point status
• - The report reviews top companies involved and
  enlists all trials (Trial title, Phase, and
  Status) pertaining to the company
• - The report provides all the unaccomplished
  trials (Terminated, Suspended and Withdrawn) with
  reason for unaccomplishment
• - The Report provides enrollment trends for the
  past five years
• - Report provides latest news for the past three
  months
• Read More At http//www.researchbeam.com/fistula-
  global-clinical-trials-review-h2-2015-market

3


Table of Content
Table of Contents 2 List of Tables 3 List of
Figures 4 Report Guidance 5 Clinical Trials by
Region 6 Clinical Trials and Average Enrollment
by Country 7 Top Countries Contributing to
Clinical Trials in Asia-Pacific 9 Top Five
Countries Contributing to Clinical Trials in
Europe 10 Top Countries Contributing to Clinical
Trials in North America 11 Top Countries
Contributing to Clinical Trials in Middle East
and Africa 12 Clinical Trials by G7 Countries
Proportion of Fistula to Other Diseases Clinical
Trials 13 Clinical Trials by Phase in G7
Countries 14 Clinical Trials in G7 Countries by
Trial Status 15 Clinical Trials by E7 Countries
Proportion of Fistula to Other Diseases Clinical
Trials 16 Clinical Trials by Phase in E7
Countries 17 Clinical Trials in E7 Countries by
Trial Status 18 Clinical Trials by Phase 19 In
Progress Trials by Phase 20 Clinical Trials by
Trial Status 21 Clinical Trials by End Point
Status 22
4


Table of Content
Subjects Recruited Over a Period of Time
23 Clinical Trials by Sponsor Type 24 Prominent
Sponsors 25 Top Companies Participating in
Fistula Therapeutics Clinical Trials 26 Prominent
Drugs 28 Latest Clinical Trials News on Fistula
29 Oct 22, 2015 Phase I Trial of Cytori Cell
Therapy for Inflammatory Bowel Disease Published
29 Clinical Trial Profile Snapshots 30 Appendix
50 Abbreviations 50 Definitions 50 Research
Methodology 51 Secondary Research 51 About
GlobalData 52 Contact Us 52 Disclaimer 52 Source
53 Enquire At http//www.researchbeam.com/fist
ula-global-clinical-trials-review-h2-2015-market/e
nquire-about-report
5



FOR MORE DETAILS
Visit us at
http//www.researchbeam.com/fistula-global-clinica
l-trials-review-h2-2015-market
Stay With Us
5933 NE Win Sivers Drive,205, Portland, OR
97220United States
TELEPHONE [phone] DIRECT 1 (503)
894-6022E-MAIL sales_at_researchbeam.com